Covaxin Overall 77.8% Effective, Claims Bharat Biotech In Final Phase 3 Data

PUBLISHED ON: July 3, 2021 | Duration: 1 min, 54 sec

facebooktwitteremailkoo
loading..
Bharat Biotech's Covaxin is overall 77.8 per cent effective "against symptomatic COVID-19", the vaccine maker said today in a statement, citing the data from the third phase of clinical trials. The data, however, is yet to be peer-reviewed.
ALSO WATCH
"A Very Big Source Of Covid Vaccines For World": Bill Gates Praises India

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com